276 related articles for article (PubMed ID: 19135537)
21. Inter-study variability of preclinical in vivo safety studies and translational exposure-QTc relationships--a PKPD meta-analysis.
Gotta V; Cools F; van Ammel K; Gallacher DJ; Visser SA; Sannajust F; Morissette P; Danhof M; van der Graaf PH
Br J Pharmacol; 2015 Sep; 172(17):4364-79. PubMed ID: 26076100
[TBL] [Abstract][Full Text] [Related]
22. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
[TBL] [Abstract][Full Text] [Related]
23. Safety pharmacology assessment of drug-induced QT-prolongation in dogs with reduced repolarization reserve.
Vormberge T; Hoffmann M; Himmel H
J Pharmacol Toxicol Methods; 2006; 54(2):130-40. PubMed ID: 16757186
[TBL] [Abstract][Full Text] [Related]
24. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
25. Application of probabilistic analysis for precisely correcting the QT interval for heart rate in telemetered common marmosets.
Honda M; Komatsu R; Holzgrefe HH; Yamada Y; Isobe T; Kimura K; Itoh T; Tamaoki N; Tabo M
J Pharmacol Toxicol Methods; 2010; 61(3):264-70. PubMed ID: 20097297
[TBL] [Abstract][Full Text] [Related]
26. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation.
Takahara A; Sugiyama A; Hashimoto K
Br J Pharmacol; 2005 Oct; 146(4):561-7. PubMed ID: 16056235
[TBL] [Abstract][Full Text] [Related]
27. A novel predictive pharmacokinetic/pharmacodynamic model of repolarization prolongation derived from the effects of terfenadine, cisapride and E-4031 in the conscious chronic av node--ablated, His bundle-paced dog.
Nolan ER; Feng MR; Koup JR; Liu J; Turluck D; Zhang Y; Paulissen JB; Olivier NB; Miller T; Bailie MB
J Pharmacol Toxicol Methods; 2006; 53(1):1-10. PubMed ID: 16399550
[TBL] [Abstract][Full Text] [Related]
28. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
[TBL] [Abstract][Full Text] [Related]
29. QT interval correction assessment in the anesthetized guinea pig.
Morissette P; Regan HK; Fitzgerald K; Bernasconi S; Gerenser P; Travis J; Fanelli P; Sannajust F; Regan CP
J Pharmacol Toxicol Methods; 2015; 75():52-61. PubMed ID: 26001325
[TBL] [Abstract][Full Text] [Related]
30. A Proof-of-Concept Evaluation of JTPc and Tp-Tec as Proarrhythmia Biomarkers in Preclinical Species: A Retrospective Analysis by an HESI-Sponsored Consortium.
Boulay E; Abernathy MM; Chui R; Friedrichs GS; Gendron-Parra N; Greiter-Wilke A; Guillon JM; Koerner JE; Menard A; Steidl-Nichols J; Pierson J; Pugsley MK; Rossman EI; Strauss D; Troncy E; Valentin JP; Wisialowski T; Authier S
Int J Toxicol; 2019; 38(1):23-32. PubMed ID: 30567462
[TBL] [Abstract][Full Text] [Related]
31. Problems of heart rate correction in assessment of drug-induced QT interval prolongation.
Malik M
J Cardiovasc Electrophysiol; 2001 Apr; 12(4):411-20. PubMed ID: 11332559
[TBL] [Abstract][Full Text] [Related]
32. QT PRODACT: sensitivity and specificity of the canine telemetry assay for detecting drug-induced QT interval prolongation.
Miyazaki H; Watanabe H; Kitayama T; Nishida M; Nishi Y; Sekiya K; Suganami H; Yamamoto K
J Pharmacol Sci; 2005; 99(5):523-9. PubMed ID: 16493192
[TBL] [Abstract][Full Text] [Related]
33. Correction of QT values to allow for increases in heart rate in conscious Beagle dogs in toxicology assessment.
Tattersall ML; Dymond M; Hammond T; Valentin JP
J Pharmacol Toxicol Methods; 2006; 53(1):11-9. PubMed ID: 15886026
[TBL] [Abstract][Full Text] [Related]
34. Heart rate correction models to detect QT interval prolongation in novel pharmaceutical development.
Markert M; Shen R; Trautmann T; Guth B
J Pharmacol Toxicol Methods; 2011; 64(1):25-41. PubMed ID: 21635956
[TBL] [Abstract][Full Text] [Related]
35. ECG telemetry in conscious guinea pigs.
Ruppert S; Vormberge T; Igl BW; Hoffmann M
J Pharmacol Toxicol Methods; 2016; 81():88-98. PubMed ID: 27118261
[TBL] [Abstract][Full Text] [Related]
36. QT PRODACT: in vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation.
Ando K; Hombo T; Kanno A; Ikeda H; Imaizumi M; Shimizu N; Sakamoto K; Kitani S; Yamamoto Y; Hizume S; Nakai K; Kitayama T; Yamamoto K
J Pharmacol Sci; 2005; 99(5):487-500. PubMed ID: 16493189
[TBL] [Abstract][Full Text] [Related]
37. Bazett and Fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval.
Indik JH; Pearson EC; Fried K; Woosley RL
Heart Rhythm; 2006 Sep; 3(9):1003-7. PubMed ID: 16945790
[TBL] [Abstract][Full Text] [Related]
38. A highly sensitive canine telemetry model for detection of QT interval prolongation: studies with moxifloxacin, haloperidol and MK-499.
Chaves AA; Zingaro GJ; Yordy MA; Bustard KA; O'Sullivan S; Galijatovic-Idrizbegovic A; Schuck H; Christian DB; Hoe CM; Briscoe RJ
J Pharmacol Toxicol Methods; 2007; 56(2):103-14. PubMed ID: 17643323
[TBL] [Abstract][Full Text] [Related]
39. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of QT interval using a linear model in individual cynomolgus monkeys.
Koga T; Kuwano K; Kito G; Kanefuji K
J Pharmacol Toxicol Methods; 2007; 55(3):248-53. PubMed ID: 17141531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
